Skip to content
★ Sign in to follow
TJ

Timothy Jon Hahn

Executive
Novavax Inc
Total declarations
8
Company
1
▲ Purchases (8 ops.)
€149k
▼ Sales (0 ops.)
—

Latest filing published 03 Feb 2015 for NOVAVAX INC, €19k.

Insider track record

Disclosed buys
8
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
8
Positive at T+90
75%
Median T+90
+38.4%

Based on 8 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 03 Feb 2015 · 4297 days ago · €19k
    -39.7%
    Entry US$159.60 · Close at T+365 US$96.20
  • Filed 03 Oct 2014 · 4420 days ago · €7,991
    +68.8%
    Entry US$84.00 · Close at T+365 US$141.80
  • Filed 26 Sept 2014 · 4427 days ago · €23k
    +88.7%
    Entry US$86.40 · Close at T+365 US$163.00
  • Filed 04 Aug 2014 · 4480 days ago · €16k
    +149.3%
    Entry US$91.60 · Close at T+365 US$228.40
  • Filed 04 Feb 2014 · 4661 days ago · €16k
    +52.4%
    Entry US$104.60 · Close at T+365 US$159.40

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Timothy Jon Hahn: trading record in brief

Timothy Jon Hahn is a declared insider of Novavax Inc, with filings sourced from SEC (Form 4). The record holds 8 filings, for trades running from 14 May 2012 to 31 January 2015.

The open-market record is one-sided, with 8 purchases worth €149k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2015 to date brings 1 purchase and no sales.

In size, the median ticket on the buying side is €17k. Looking at 8 purchases old enough to measure, the stock rose over the following 90 days in 75% of cases; the median change was +38.4%. They describe history only and say nothing certain about the share price ahead.

On 3 February 2015 came the latest disclosure, an open-market purchase for €19k in Novavax Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Timothy Jon Hahn

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations8 total
  • ▲
    SVP, ManufacturingExecutivesNovavax Inc
    21,270 USD0SEC
    9,329 shares@ US$2.28Common StockSEC:0001209191-15-008929:0
    Canonical exit: 1 May 2015 (T+90)
  • ▲
    SVP, ManufacturingExecutivesNovavax Inc
    10,125 USD0SEC
    2,500 shares@ US$4.05Common StockSEC:0001209191-14-061715:0
    Canonical exit: 1 Jan 2015 (T+90)
  • ▲
    SVP, ManufacturingExecutivesNovavax Inc
    8,273 USD0SEC
    1,984 shares@ US$4.17Common StockSEC:0001209191-14-059989:0
    Canonical exit: 24 Dec 2014 (T+90)
  • ▲
    SVP, ManufacturingExecutivesNovavax Inc
    29,257 USD0SEC
    7,016 shares@ US$4.17Common StockSEC:0001209191-14-059989:1
    Canonical exit: 24 Dec 2014 (T+90)
  • ▲
    SVP, Manufacturing & PDExecutivesNovavax Inc
    21,067 USD0SEC
    9,240 shares@ US$2.28Common StockSEC:0001209191-14-050161:0
    Canonical exit: 29 Oct 2014 (T+90)
  • ▲
    SVP, Manufacturing & PDExecutivesNovavax Inc
    21,563 USD0SEC
    9,416 shares@ US$2.29Common StockSEC:0001209191-14-006707:0
    Canonical exit: 1 May 2014 (T+90)
  • ▲
    SVP, Manufacturing & PDExecutivesNovavax Inc
    39,480 USD0SEC
    21,000 shares@ US$1.88Common StockSEC:0001209191-13-031751:0
    Canonical exit: 8 Sept 2013 (T+90)
  • ▲
    SVP, Manufacturing & PDExecutivesNovavax Inc
    39,900 USD0SEC
    30,000 shares@ US$1.33Common StockSEC:0001209191-12-028519:0
    Canonical exit: 12 Aug 2012 (T+90)

8 of 8 declarations